Identification of a Papain-Like Protease Inhibitor with Potential for Repurposing in Combination with an Mpro Protease Inhibitor for Treatment of SARS-CoV-2. acbr. 2022;6(6):993-1002. Accessed September 20, 2026. https://www.fortunejournals.org/ojs/index.php/acbr/article/view/14979